EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.4.1.90 | Adenocarcinoma |
11588157 |
Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. |
ongoing research unassigned |
2 0 |
2.4.1.90 | Arthritis, Rheumatoid |
20490888 |
beta1,4-Galactosyltransferase-I contributes to the inflammatory processes in synovial tissue of patients with rheumatoid arthritis. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 3 |
2.4.1.90 | Asthma |
27901618 |
Genome-wide Interaction Analysis of Air Pollution Exposure and Childhood Asthma with Functional Follow-up. |
therapeutic application unassigned |
4 0 |
2.4.1.90 | Astrocytoma |
11501750 |
Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma. |
causal interaction diagnostic usage ongoing research unassigned |
4 2 4 0 |
2.4.1.90 | Astrocytoma |
12385586 |
Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line. |
causal interaction diagnostic usage ongoing research unassigned |
3 3 4 0 |
2.4.1.90 | Atherosclerosis |
16311884 |
Platelet derived growth factor recruits lactosylceramide to induce cell proliferation in UDP Gal:GlcCer: beta1 --> 4Galactosyltransferase (GalT-V) mutant Chinese hamster ovary cells. |
causal interaction unassigned |
3 0 |
2.4.1.90 | Biliary Tract Neoplasms |
11914601 |
Overexpression of beta 1,4N-acetylgalactosaminyl- transferase mRNA as a molecular marker for various types of cancers. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 4 4 4 |
2.4.1.90 | Breast Neoplasms |
9435216 |
Molecular cloning of a human cDNA encoding beta-1,4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc beta-1,4-galactosyltransferase. |
ongoing research unassigned |
4 0 |
2.4.1.90 | Breast Neoplasms |
32599982 |
?1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/?-catenin Signaling Pathway. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 4 4 4 |
2.4.1.90 | Carcinogenesis |
17470362 |
beta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization. |
causal interaction ongoing research therapeutic application unassigned |
3 4 3 0 |